Skip to main content

Bioinformatics Startup Takes Exclusive License to Software from U. of Houston

NEW YORK (GenomeWeb News) - The University of Houston said yesterday that it has exclusively licensed a set of bioinformatics software tools to startup Eureka Genomics.
 
Eureka Genomics is a University of Houston spinoff that was founded last year. The company is developing bioinformatics products for use in healthcare, agriculture, pathogen surveillance, and other biotechnology applications.
 
The university said that the software tools, which were developed by UH associate professor Yuriy Fofanov and colleagues, have applications in personalized medicine, pathogen detection, and next-generation sequencing. The university said in a statement that the tools can be used as “building blocks” for “a variety of applications requiring advanced genomic sequence analysis,” but did not provide further details.
 
The University’s Center for Industrial Partnerships arranged the licensing agreement.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.